ELOS B — Elos Medtech AB Share Price
- SEK1.64bn
- SEK1.52bn
- SEK888.54m
- 82
- 28
- 21
- 37
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.08 | ||
Price to Tang. Book | 3.52 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 1.61 | ||
EV to EBITDA | 7.82 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 9.75% | ||
Return on Equity | 6.86% | ||
Operating Margin | 12.17% |
Financial Summary
Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | SEKm | 644.71 | 689.4 | 580 | 723.58 | 888.54 | n/a | n/a | 8.98% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -17.82 | +68.62 | -81.62 | +980.35 | -0.22 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Elos Medtech AB is a Sweden-based medical device company. The Company is engaged in the development, manufacturing and sale of medical technology products and components, with focus on dental and orthopedic implants and instruments. The Company's products include implants, prosthetics, digital dentistry, screws, drills, plates, pins and wires, as well as other metal instruments, and injection molded disposable plastics, such as caps, tubes, vials, dishes and fittings for high-performance liquid chromatography (HPCL) used in diagnostics. The Company offers also customized turnkey solutions. It has operating facilities in Sweden, Denmark, China and the United States, and distributes its products worldwide.
Directors
- Lovisa Lander CHM (36)
- Jan Wahlstrom PRE (54)
- Ewa Linsater CFO (51)
- Mathias Andersson CEX (50)
- Jodie Gilmore CEX (50)
- Conny Jakobsson CEX (52)
- Soeren Olesen CEX (60)
- Sam Svannel CEX
- Malin Gustavsson DMK (49)
- Anders Bjorklund OTH (46)
- Birker Bahnsen DRC
- Alexander Cicetti DRC
- Stefano Alfonsi IND (57)
- Claes Hansson IND (64)
- Hanna Wilkman IND (54)
- Last Annual
- December 31st, 2022
- Last Interim
- September 30th, 2023
- Incorporated
- June 9th, 1923
- Public Since
- June 13th, 1989
- No. of Shareholders
- 3,249
- No. of Employees
- 653
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
OMX Nordic Exchange Stockholm
- Shares in Issue
- 8,068,000

- Address
- Torsgatan 5B, GOETEBORG, 411 04
- Web
- https://elosmedtech.se/
- Phone
- +46 510484360
- Auditors
- KPMG AB
Upcoming Events for ELOS B
Elos Medtech AB Annual Shareholders Meeting
Q1 2024 Elos Medtech AB Earnings Release
Similar to ELOS B
Acarix AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Aegirbio AB
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
FAQ
As of Today at 18:07 UTC, shares in Elos Medtech AB are trading at SEK203.00. This share price information is delayed by 15 minutes.
Shares in Elos Medtech AB last closed at SEK203.00 and the price had moved by -19.92% over the past 365 days. In terms of relative price strength the Elos Medtech AB share price has underperformed the FTSE Global All Cap Index by -28.52% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Elos Medtech AB dividend yield is 0.49% based on the trailing twelve month period.
Last year, Elos Medtech AB paid a total dividend of SEK1.00, and it currently has a trailing dividend yield of 0.49%. We do not have any data on when Elos Medtech AB is to next pay dividends.
We do not have data on when Elos Medtech AB is to next pay dividends. The historic dividend yield on Elos Medtech AB shares is currently 0.49%.
To buy shares in Elos Medtech AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK203.00, shares in Elos Medtech AB had a market capitalisation of SEK1.64bn.
Here are the trading details for Elos Medtech AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: ELOS B
Based on an overall assessment of its quality, value and momentum Elos Medtech AB is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Elos Medtech AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -0.48%.
As of the last closing price of SEK203.00, shares in Elos Medtech AB were trading -5.05% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Elos Medtech AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK203.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Elos Medtech AB's management team is headed by:
- Lovisa Lander - CHM
- Jan Wahlstrom - PRE
- Ewa Linsater - CFO
- Mathias Andersson - CEX
- Jodie Gilmore - CEX
- Conny Jakobsson - CEX
- Soeren Olesen - CEX
- Sam Svannel - CEX
- Malin Gustavsson - DMK
- Anders Bjorklund - OTH
- Birker Bahnsen - DRC
- Alexander Cicetti - DRC
- Stefano Alfonsi - IND
- Claes Hansson - IND
- Hanna Wilkman - IND